Application of clinopodium chinense total flavones in preparing medicines for protection effect of adriamycin-induced cardiotoxicity
A protective, cardiotoxic technology, applied in the field of medicine, can solve the problem of lack of effective prevention and treatment methods
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] Example 1 The protective effect of total flavonoids of Campanula chinensis combined with doxorubicin on the myocardium in vivo
Embodiment 11
[0023] Example 1.1 Establishment of Rat Cardiomyopathy Model Induced by Doxorubicin in Vivo
[0024] SD rats aged 6-8 weeks (Beijing Weitong Lihua, Beijing, China). Animals were acclimated for 1 week with free access to food and water. 80 rats were randomly divided into 6 groups: normal control group (control); single-administration group of total flavonoids of Pinnata chinensis (TFCC, 80mg / kg); doxorubicin model group (DOX, 3mg / kg); doxorubicin Combined administration with total flavonoids of Campanula chinensis (20, 40, 80mg / kg). The normal group and the model group were given pure water orally, and the other groups were given TFCC of the same volume and corresponding concentration. After 15 days, the model group and the combined administration group were intraperitoneally injected with doxorubicin every other day, a total of 3 times, and the other groups were injected with the same volume of normal saline. Treatment was performed 14 days after the last dose.
Embodiment 12
[0025] Example 1.2 Comparison of heart weight and body weight and detection of myocardial three enzymes
[0026] Body weight was weighed, and blood was collected from the abdominal aorta under chloral hydrate anesthesia. Blood samples were centrifuged at 3000 g for 10 minutes within one hour after collection, and then the activities of LDH, AST, and CK in plasma were determined by commercial detection kits purchased from Jiancheng Bio-engineering Institute (Nanjing, China) according to the manufacturer's instructions.
[0027] The result is as figure 1 As shown in -A, compared with the normal group, the heart weight and body weight of the doxorubicin group decreased significantly, while the combined administration group could significantly increase. Such as figure 1 -B, the content of myocardial three enzymes in the blood of the Adriamycin group increased significantly, while that of the combined administration group decreased significantly.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com